Literature DB >> 17665245

Increased risk of lymph node metastasis in multifocal hereditary and sporadic medullary thyroid cancer.

Andreas Machens1, Steffen Hauptmann, Henning Dralle.   

Abstract

BACKGROUND: In sporadic and hereditary medullary thyroid cancer, tumor multifocality may constitute an independent risk factor of lymph node metastasis on top of primary tumor size when the diameter of the largest primary tumor is the same.
METHODS: Included in this institutional cohort study were 232 consecutive patients operated on at our institution for hitherto untreated medullary thyroid cancer. Associations of clinicopathologic variables with lymph node metastasis were investigated simultaneously using multivariate Cox regression analysis.
RESULTS: On univariate analysis, multifocal cancers developed lymph node metastases significantly more often (p < or = 0.005) than unifocal cancers, in both the sporadic (90% vs. 41%) and the hereditary setting (48% vs. 14%). On multivariate Cox regression analysis on lymph node metastasis as a function of primary tumor diameter, only multifocal (vs. unifocal) tumor growth was significantly associated with lymph node metastasis (odds ratio [OR] = 2.5; p = 0.01). When multifocal growth was removed as an independent variable from the Cox model, heredity became the only significant predictor (OR = 3.1; p < 0.0001).
CONCLUSION: The excess risk of lymph node metastasis of 34%-49% in multifocal medullary thyroid cancer seems to be caused by concurrent smaller thyroid cancers. A diagnosis of more than one medullary thyroid cancer signifies a higher risk of lymph node metastasis, warranting systematic lymph node dissection.

Entities:  

Mesh:

Year:  2007        PMID: 17665245     DOI: 10.1007/s00268-007-9185-1

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.282


  15 in total

1.  Improved prediction of calcitonin normalization in medullary thyroid carcinoma patients by quantitative lymph node analysis.

Authors:  A Machens; O Gimm; J Ukkat; R Hinze; U Schneyer; H Dralle
Journal:  Cancer       Date:  2000-04-15       Impact factor: 6.860

2.  Prospects of remission in medullary thyroid carcinoma according to basal calcitonin level.

Authors:  Andreas Machens; Ulrich Schneyer; Hans-Jürgen Holzhausen; Henning Dralle
Journal:  J Clin Endocrinol Metab       Date:  2005-01-05       Impact factor: 5.958

3.  [Guidelines in oncologic surgery--malignant thyroid tumors].

Authors:  H D Röher; D Simon; P E Goretzki
Journal:  Langenbecks Arch Chir Suppl Kongressbd       Date:  1997

4.  Sporadic versus familial medullary thyroid microcarcinoma: a histopathologic study of 50 consecutive patients.

Authors:  K Kaserer; C Scheuba; N Neuhold; A Weinhäusel; O A Haas; H Vierhapper; B Niederle
Journal:  Am J Surg Pathol       Date:  2001-10       Impact factor: 6.394

5.  Impact of modified radical neck dissection on biochemical cure in medullary thyroid carcinomas.

Authors:  T Weber; T Schilling; K Frank-Raue; M Colombo-Benkmann; U Hinz; R Ziegler; E Klar
Journal:  Surgery       Date:  2001-12       Impact factor: 3.982

6.  Lymph node involvement in macroscopic medullary thyroid carcinoma.

Authors:  P Tamagnini; M Iacobone; F Sebag; M Marcy; C De Micco; J F Henry
Journal:  Br J Surg       Date:  2005-04       Impact factor: 6.939

7.  Early malignant progression of hereditary medullary thyroid cancer.

Authors:  Andreas Machens; Patricia Niccoli-Sire; Josef Hoegel; Karin Frank-Raue; Theo J van Vroonhoven; Hans-Dietrich Roeher; Robert A Wahl; Peter Lamesch; Friedhelm Raue; Bernard Conte-Devolx; Henning Dralle
Journal:  N Engl J Med       Date:  2003-10-16       Impact factor: 91.245

8.  Sporadic medullary microcarcinoma of the thyroid: a retrospective analysis of eighty cases.

Authors:  N Beressi; J M Campos; J P Beressi; B Franc; P Niccoli-Sire; B Conte-Devolx; A Murat; P Caron; L Baldet; J L Kraimps; R Cohen; J C Bigorgne; O Chabre; P Lecomte; E Modigliani
Journal:  Thyroid       Date:  1998-11       Impact factor: 6.568

9.  Incidentally found medullary thyroid cancer: treatment rationale for small tumors.

Authors:  Andreas Raffel; Kenko Cupisti; Markus Krausch; Achim Wolf; Klaus-Martin Schulte; Hans-Dietrich Röher
Journal:  World J Surg       Date:  2004-03-04       Impact factor: 3.352

10.  Primary hereditary medullary thyroid carcinoma--C-cell morphology and correlation with preoperative calcitonin levels.

Authors:  R Hinze; H J Holzhausen; O Gimm; H Dralle; F W Rath
Journal:  Virchows Arch       Date:  1998-09       Impact factor: 4.064

View more
  20 in total

Review 1.  Occult primary medullary thyroid carcinoma presenting with pituitary and parotid metastases: case report and review of the literature.

Authors:  Andrea Conway; Andres Wiernik; Ajay Rawal; Cornelius Lam; Hector Mesa
Journal:  Endocr Pathol       Date:  2012-06       Impact factor: 3.943

Review 2.  Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.

Authors:  Samuel A Wells; Sylvia L Asa; Henning Dralle; Rossella Elisei; Douglas B Evans; Robert F Gagel; Nancy Lee; Andreas Machens; Jeffrey F Moley; Furio Pacini; Friedhelm Raue; Karin Frank-Raue; Bruce Robinson; M Sara Rosenthal; Massimo Santoro; Martin Schlumberger; Manisha Shah; Steven G Waguespack
Journal:  Thyroid       Date:  2015-06       Impact factor: 6.568

Review 3.  Multi-targeted approach in the treatment of thyroid cancer.

Authors:  B Zarebczan; H Chen
Journal:  Minerva Chir       Date:  2010-02       Impact factor: 1.000

Review 4.  New developments in the diagnosis and treatment of thyroid cancer.

Authors:  David F Schneider; Herbert Chen
Journal:  CA Cancer J Clin       Date:  2013-06-24       Impact factor: 508.702

Review 5.  [Hereditary thyroid cancer].

Authors:  H Dralle; A Machens; K Lorenz
Journal:  Chirurg       Date:  2008-11       Impact factor: 0.955

Review 6.  German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors.

Authors:  Henning Dralle; Thomas J Musholt; Jochen Schabram; Thomas Steinmüller; Andreja Frilling; Dietmar Simon; Peter E Goretzki; Bruno Niederle; Christian Scheuba; Thomas Clerici; Michael Hermann; Jochen Kußmann; Kerstin Lorenz; Christoph Nies; Peter Schabram; Arnold Trupka; Andreas Zielke; Wolfram Karges; Markus Luster; Kurt W Schmid; Dirk Vordermark; Hans-Joachim Schmoll; Reinhard Mühlenberg; Otmar Schober; Harald Rimmele; Andreas Machens
Journal:  Langenbecks Arch Surg       Date:  2013-03-03       Impact factor: 3.445

7.  [Surgery of thyroid carcinoma].

Authors:  H Dralle; K Lorenz; A Machens
Journal:  Chirurg       Date:  2009-11       Impact factor: 0.955

8.  Can the early reduction of tumour markers predict outcome in surgically treated sporadic medullary thyroid carcinoma?

Authors:  Per Bümming; Håkan Ahlman; Bengt Nilsson; Ola Nilsson; Bo Wängberg; Svante Jansson
Journal:  Langenbecks Arch Surg       Date:  2008-07-15       Impact factor: 3.445

9.  Routine preoperative (111)In-octreotide scintigraphy in patients with medullary thyroid cancer.

Authors:  Jakob Dahlberg; Per Bümming; Peter Gjertsson; Svante Jansson
Journal:  Langenbecks Arch Surg       Date:  2013-05-19       Impact factor: 3.445

Review 10.  Current understanding and management of medullary thyroid cancer.

Authors:  Madhuchhanda Roy; Herbert Chen; Rebecca S Sippel
Journal:  Oncologist       Date:  2013-09-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.